Skip to main content
. 2016 Jan 28;17(4):371–380. doi: 10.1080/15384047.2016.1139268

Figure 6.

Figure 6.

At an equivalent hematoxicity level, antitumor activity of evofosfamide and ifosfamide in the H460 ectopic xenograft models. Evo, was given at 50 mg/kg, ip, and Ifo was given at 30 mg/kg ip at a regimen of QDx5/wk × 2 wks; A, antitumor activity as monotherapy. B, sunitinib was given at 80 mg/kg, QDx19, oral. Evo or Ifo was given 7 d after the initiation of sunitinib treatment. Data are expressed as Mean ± SEM of 10 animals per group.